Stereotaxis STXS reached a significant milestone last Wednesday when NVIDIA NVDA took its name for the NVIDIA Connect program. Following the news, Stereotaxis' stock jumped more than 15%, reflecting ...
Surgical robotics company Stereotaxis' (STXS) shares fell 12% in early trading on Wednesday as the company reported a wider loss in the quarter, and revenue fell 19%, missing Street estimates.
ST. LOUIS, May 24, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has ...
Good afternoon. Thank you for joining us for Stereotaxis’ First Quarter 2025 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to follow may relate ...
Stereotaxis STXS recently announced the achievement of the CE mark approval of its next-generation robotic system, GenesisX, in Europe. Simultaneously, the company has submitted a 510(k) application ...
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results